Immune Activation Anti-Cancer Antiviral Gut Health Metabolic Patents
Home›Topics› Immune Activation
Research Topic

Immune Activation

How Aureobasidium pullulans β-1,3/1,6-glucan activates macrophages, NK cells, and dendritic cells through Dectin-1 and CR3 receptor pathways.

60+ Studies Dectin-1 Primary Receptor NK / Macrophage / DC Cell Targets In vitro · In vivo · RCT
Direct Answer

Aureobasidium pullulans beta glucan activates innate immunity by binding Dectin-1 receptors on macrophages and dendritic cells, triggering NF-κB → cytokine production (TNF-α, IL-6, IL-12). It also binds CR3 on NK cells, priming cytotoxic activity against tumor cells. A third, Dectin-1-independent pathway upregulates interferon-stimulated genes (ISGs) — providing antiviral immune priming. This triple-pathway activation is documented across 60+ peer-reviewed studies.

Mechanism of Action

Three Immune Activation Pathways

Beta glucan from Aureobasidium pullulans activates innate immunity via distinct but complementary pathways depending on cell type and receptor.

Dectin-1 Pathway

β-1,3/1,6-glucan binds Dectin-1 (CLEC7A) on macrophages and dendritic cells → Syk kinase → Card9 → NF-κB activation → TNF-α, IL-6, IL-12 production + enhanced phagocytosis.

CR3 Pathway

Beta glucan binds Complement Receptor 3 (CR3/CD11b) on NK cells → priming for enhanced cytotoxic activity against tumor cells and virus-infected cells via perforin/granzyme release.

Dectin-1 Independent

A third pathway documented in macrophage studies: beta glucan upregulates interferon-stimulated genes (ISGs) — OAS1, MX1, IFIT1 — independent of Dectin-1. Relevant to antiviral immune priming.

Innate → Adaptive Bridge

Dendritic cells activated by beta glucan produce IL-12, driving T cell differentiation toward Th1 responses. This bridge from innate to adaptive immunity is studied in the context of anti-tumor vaccine adjuvancy.

Phagocytosis Enhancement

Dectin-1 activation increases macrophage phagocytic activity — the ability to engulf and destroy pathogens and dead cells. Measured by fluorescent bead uptake assays in multiple in vitro studies.

Oral Absorption Evidence

A stable isotope tracer study (²H-labeled beta glucan) confirmed intestinal absorption and detection in peripheral blood — evidence that orally administered Aureobasidium beta glucan reaches systemic immune cells.

Key Studies

Landmark Immune Activation Research

Selected peer-reviewed studies documenting immune activation by Aureobasidium pullulans beta glucan.

In Vitro
In Vitro: Macrophage Activation via Dectin-1 Signaling
TNF-α, IL-6, and IL-12 production confirmed in macrophage cell lines following beta glucan treatment. Syk kinase inhibition abolished response, confirming Dectin-1 pathway specificity.
Journal of Immunology · DOI-verified
In Vivo
In Vivo: NK Cell Activity Enhancement by Oral Aureobasidium Beta Glucan
Oral beta glucan administration increased splenic NK cell cytotoxic activity vs. control in animal studies. CR3 receptor binding confirmed as the mechanism for NK cell activation.
Bioscience, Biotechnology, and Biochemistry · Indexed in Research Archive
In Vitro
In Vitro: Dectin-1-Independent ISG Upregulation in Human Macrophages
Aureobasidium beta glucan upregulated ISGs (OAS1, MX1, IFIT1) in macrophages without Dectin-1 involvement — documenting a novel antiviral immune priming pathway.
Antiviral Research · DOI-verified
RCT
RCT: Oral Beta Glucan and NK Cell Activity in Healthy Adults
Double-blind RCT in healthy volunteers documented significant increase in NK cell activity vs. placebo following oral beta glucan supplementation. No significant adverse events reported.
Nutrients · DOI-verified · PMID indexed
View All Immune Studies in Archive
Common Questions

Immune Activation FAQ

Beta glucan from Aureobasidium pullulans binds Dectin-1 receptors on macrophages and dendritic cells, triggering NF-κB signaling that drives cytokine production (TNF-α, IL-6, IL-12). It also binds CR3 on NK cells to enhance cytotoxicity. A separate Dectin-1-independent pathway upregulates antiviral interferon-stimulated genes (ISGs).
Primary targets are macrophages (via Dectin-1), NK cells (via CR3), and dendritic cells (via Dectin-1). Secondary effects include neutrophil priming and T cell activation through dendritic cell IL-12 production (innate-to-adaptive bridge).
Yes. A ²H-labeled stable isotope tracer study confirmed intestinal absorption and detection of Aureobasidium beta glucan in peripheral blood after oral administration. Multiple RCTs use oral dosing and document systemic immune effects — confirming that orally administered beta glucan reaches systemic immune cells.
Documented cytokines include TNF-α, IL-6, IL-12, and IFN-γ via the Dectin-1 pathway, and Type I interferons (IFN-α/β) via the Dectin-1-independent ISG pathway. Cytokine profiles vary by cell type, dose, and assay conditions.

Browse All Immune Activation Studies

60+ indexed studies with abstracts, AI summaries, DOI links, and PMID references in the Research Archive.

Open Research Archive